Cephadroxil

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cephadroxil

Quick Facts

Property Description
Active ingredient Cefadroxil (INN)
Form Capsule, Tablet, Oral suspension
Pharmacological class First-generation Cephalosporin, Antibiotic
Common use Systemic treatment of bacterial infections
Origin Semi-synthetic beta-lactam derivative

What Type of Antibiotic is Cefadroxil?

Cefadroxil is a semi-synthetic antibiotic belonging to the cephalosporin family of drugs. It is specifically classified as a first-generation cephalosporin, which dictates its core chemical properties and general spectrum of activity against susceptible bacteria. The active compound is Cefadroxil, sometimes referenced by its historical spelling, Cephadroxil. Cefadroxil is a clinically recognized agent for treating susceptible bacterial infections.


Cefadroxil: Composition and Available Forms

The medicine is supplied as a single-ingredient product, containing only the active compound Cefadroxil alongside necessary pharmaceutical excipients. The product is strictly intended for oral administration and is manufactured in several distinct dosage forms, including a capsule, a tablet, and an oral suspension. Notably, the availability of the oral suspension form establishes its versatility for patients who require a liquid vehicle base to facilitate easier swallowing, such as pediatric patients.


What is the General Purpose of Cefadroxil?

The general purpose of Cefadroxil is to act as an effective antibacterial agent through a bactericidal action against susceptible pathogens. This means Cefadroxil actively kills the bacteria causing the infection by disrupting their fundamental structure. This killing effect is achieved by Cefadroxil directly targeting and interrupting the process of bacterial cell wall synthesis. By destroying the structural integrity of the bacterial cells, the medicine eliminates the underlying bacterial population, which constitutes its primary therapeutic benefit.

What side effects are possible with Cephadroxil?

Possible Side Effects and Safety Information

Official regulatory documents classify the possible adverse effects of Cephadroxil by frequency and the body system affected. These classifications establish the medicine's documented safety profile, focusing on both common and rare events.


Adverse Reaction Scope

Classification Documented Scope Frequency Classification
Gastrointestinal & Skin Nausea, vomiting, diarrhea, rash, pruritus Common (1% to 10%)
Infections Vaginal mycoses Uncommon (0.1% to 1%)
Renal & Immune Interstitial nephritis, angioedema Rare (0.01% to 0.1%)

Serious Adverse Reactions and Safety Constraints

Regulatory authorities explicitly document the potential for severe, though infrequent, adverse reactions. These include Anaphylactic Shock, which is a severe immediate hypersensitivity response, and serious intestinal conditions such as Pseudomembranous Colitis and Clostridium difficile-associated diarrhea (CDAD). Severe skin reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are also listed as possible.

Safety constraints noted in official labeling include the potential for cross-allergenicity for individuals with a known penicillin allergy. The risk of superinfection (e.g., fungal overgrowth) is associated with prolonged use. Furthermore, the safety profile notes that CDAD may manifest during treatment or up to two months following discontinuation. Caution is specifically advised for patients with existing Renal Impairment and a history of Gastrointestinal Disease due to the need for monitoring and potential adjustment of treatment duration.

Overdose and Emergency Response

Overdose Manifestations and Toxic Reactions

An officially documented overdose of Cephadroxil primarily involves central nervous system (CNS) effects and gastrointestinal distress. Documented signs of toxicity may include seizures (convulsions), reduced consciousness, muscular fasciculations, myoclonia, and coma in severe cases. Gastrointestinal symptoms like nausea, vomiting, and diarrhea are also noted. Serious systemic manifestations that may occur include electrolytic disorders, acidosis, and kidney insufficiency. This toxic profile is classified as requiring acute intervention.


When to Seek Immediate Medical Help

Regulatory agencies mandate that immediate medical attention be sought if an overdose is suspected. Specifically, emergency services (911) must be contacted without delay if the affected person exhibits severe symptoms such as having a seizure, trouble breathing, being unable to be awakened, or collapsing.


Official Overdose Management

Management is symptomatic and supportive, as no specific antidote is known for Cephadroxil overdose. Procedures such as gastric emptying and administration of activated charcoal are described in the official prescribing information as potential management steps. A critical consideration noted in regulatory labeling is the increased risk of severe neurological symptoms in patients with impaired renal function, potentially requiring specialized monitoring or procedures, such as dialysis, due to slower drug clearance.

Therapeutic Uses of Cephadroxil

What Cefadroxil Treats: Main Uses and Benefits

Cefadroxil is commonly used to help with infections caused by susceptible bacteria across several key body systems, providing supportive relief when symptoms interfere with routine activities. This medication is applicable within clinical settings that involve acute or disruptive symptom patterns stemming from infections in the skin and soft tissues (such as cellulitis and impetigo), the urinary tract (like uncomplicated cystitis), and the upper respiratory tract (such as streptococcal pharyngitis and tonsillitis).

The medicine is relevant for managing symptom clusters that create noticeable physiological strain, may help ease the overall symptom load during symptomatic periods. It is generally used across domains where additional symptomatic support is needed and may assist with reducing the risk of developing serious systemic complications, particularly when treating Group A Streptococcus. It is also used in specific scenarios as a preventative measure (prophylaxis) before certain medical procedures to help with risk reduction for infective endocarditis.

“The medication supports the patient during difficult episodes by easing distress and assists with maintaining functional stability.”

Quick Fact: Focus on Localized Pain and Swelling

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The official regulatory profile for Cephadroxil establishes clear guidelines for patient eligibility based on allergy status, organ function, and physiological state.


Contraindicated Populations

Cephadroxil is strictly contraindicated for individuals with a known allergy to the cephalosporin group of antibiotics. Caution is also mandatory for patients with a history of severe reactions to penicillins or other beta-lactam drugs due to the documented risk of cross-allergenicity.


Restricted or Conditional Use

Population/Condition Eligibility Status (Regulatory)
Renal Impairment Restricted: Use with caution and requires dose adjustment if Creatinine Clearance is below 50 mL/min/1.73 m^2 to prevent accumulation.
Pregnancy Conditional: Classified as Pregnancy Category B (FDA). Use is generally not recommended unless clearly needed, as safety has not been fully established.
Lactation Conditional: Drug is excreted into breast milk. Some regulatory sources advise discontinuing breastfeeding; others advise caution.
Gastrointestinal History Caution: Individuals with a history of colitis or severe diarrhea must use with caution due to the risk of exacerbating the condition.

Age-Related Eligibility: Dosage is established for children beyond the neonatal period. Older adults may require monitoring of kidney function due to age-related decline, which affects drug clearance.

What should I know about interactions with other medicines?

Cephadroxil, an oral cephalosporin antibiotic, can interact with various other medications, potentially altering its effects or increasing the risk of adverse reactions. It is crucial to inform a healthcare professional about all prescription and over-the-counter drugs, as well as any supplements, vitamins, or herbal products being taken.

Potential Drug Interactions

Interacting Medication Class Potential Effect
Probenecid (used for gout) May significantly increase the concentration of Cephadroxil in the body, which could raise the risk of side effects. This combination is generally avoided.
Anticoagulants (e.g., Warfarin) May increase the risk of bleeding. Close monitoring of blood clotting time (INR) is advised if these medications are used together.
Other Nephrotoxic Drugs (affecting the kidneys) Concurrent use of Cephadroxil with other medications that can be harmful to the kidneys, such as certain diuretics or aminoglycoside antibiotics, may increase the overall risk of kidney toxicity.
Live Vaccines (e.g., Typhoid, Cholera) Cephadroxil may reduce the effectiveness of certain live bacterial vaccines. Consult a physician about vaccine scheduling.

Other Considerations

  • Oral Contraceptives: Like other broad-spectrum antibiotics, Cephadroxil may potentially reduce the effectiveness of some oral contraceptives. It is advisable to consider using a non-hormonal barrier method of contraception during treatment.
  • Laboratory Tests: Cephadroxil can cause false-positive results in certain urine glucose tests (using copper-reduction methods) and in the Coombs' test, which detects antibodies on red blood cells.

Mechanism of Action

How Cefadroxil Works: Mechanism of Action

Cefadroxil, a beta-lactam antibiotic, acts by directly interfering with the construction of the bacterial cell wall, a mechanism that results in the physical destruction of susceptible organisms.

Irreversible Blockade of Bacterial Cell Structure

The primary molecular action involves Cefadroxil functioning as a covalent inhibitor of Penicillin-Binding Proteins (PBPs), bacterial enzymes essential for building the cell wall. By binding irreversibly to these enzymes, the drug prevents the necessary cross-linking of peptidoglycan strands, the structural mesh of the cell wall.

Pathogen Lysis and Reduced Microbial Concentration

The consequence of structural failure initiates a sequence of physiological events: the weakened bacterial cell cannot withstand its own internal osmotic pressure, leading to swelling and rupture (lysis). This action is bactericidal, resulting in the destruction of susceptible microorganisms. The result is a decrease in the concentration of susceptible bacteria within the system.

Limitations Due to Enzyme Interference

The drug’s mechanism is overcome if the bacteria produce beta-lactamase enzymes, which hydrolyze and inactivate the Cefadroxil molecule before it reaches the PBP targets. Alternatively, bacteria may possess modified PBPs that do not bind the drug effectively, neutralizing the structural inhibition mechanism.

Dosage and Administration Information

Administration Route and Dosing Schedule

Cephadroxil is formulated exclusively for oral administration, available as capsules (500 mg), tablets (1 g), and a powder for oral suspension. Standard adult dosing is strictly defined by the clinical scenario, typically ranging from 1 gram to 2 grams per day. The dosing frequency follows one of two primary patterns: either once daily or in two equally divided doses (b.i.d.), with the specific regimen determined by the prescribing information for the infection type.


Intake Context and Duration

The medication may be taken with or without food, as official labeling indicates this does not affect the drug's absorption. Taking the dose with food may be employed to diminish the potential for gastrointestinal discomfort. For the liquid form, the suspension must be shaken well before each use to ensure proper measurement. The duration of use is also specified; for certain infections caused by susceptible bacteria (e.g., Group A Strep), treatment must be maintained for a minimum of 10 days. The general procedural principle is to complete the full course, continuing administration for at least 48 to 72 hours after the clinical symptoms have fully resolved.


Population-Specific Rules

Official instructions mandate specific dose modification for individuals with renal impairment. The standard 1 g initial dose is followed by a reduced 500 mg maintenance dose, with the time interval between doses strictly adjusted according to the patient's measured creatinine clearance (CrCl). Pediatric dosing is based on the patient's body weight.

Recent Clinical Evidence

Phase III Clinical Trials

Research consistently suggests that Cephadroxil, a first-generation cephalosporin antibiotic, has been evaluated for its potential in managing bacterial infections, particularly those affecting the skin, skin structure, and urinary tract. Studies have compared the drug's activity against common pathogens, including Staphylococcus aureus and beta-hemolytic streptococci.

The primary evidence comes from randomized controlled trials (RCTs) that have investigated outcomes in various populations. For instance, in one large trial focused on uncomplicated urinary tract infections, the evaluation of culture cure rates was similar between patients treated with Cephadroxil and those receiving an older, frequently used oral cephalosporin.

Long-Term Safety and Special Populations

Long-term studies have primarily examined the drug's tolerability over defined treatment periods. Adverse event rates in the active treatment groups were recorded in comparison to control groups, with gastrointestinal issues (such as nausea and diarrhea) being among the most frequently observed. These effects are typically mild and transient.

In special populations, clinical trials have focused on pediatric and geriatric groups. For children with musculoskeletal infections, research has focused on the drug's pharmacokinetic profile to guide appropriate dosing for oral step-down therapy. For older patients, clinical evaluation and dosage adjustments are often necessary due to the higher likelihood of age-related kidney function changes, which can affect the drug’s elimination rate.

Key Studies & References

  1. Cephalosporin-related adverse drug reactions and clinical tolerance

Frequently Asked Questions (FAQ)

Common questions about Cephadroxil (FAQ)

Q: What is Cephadroxil, and how does it work?

Cephadroxil is a cephalosporin antibiotic used to treat certain bacterial infections. It works by interfering with the ability of bacteria to build their protective cell walls. This action kills the bacteria and treats the infection.

Q: What types of infections does Cephadroxil treat?

Cephadroxil is commonly prescribed for infections caused by certain susceptible bacteria. These typically include:

  • Skin and soft tissue infections
  • Throat infections (like pharyngitis/tonsillitis caused by Streptococcus pyogenes)
  • Urinary tract infections (UTIs)

It is not effective against viral infections like the common cold or flu.

Q: How long does it take for Cephadroxil to work?

While the antibiotic starts working immediately after you take it, you may not notice an improvement in your symptoms right away. Most people begin to feel better within a few days of starting treatment. It is crucial to complete the full course of medication as prescribed, even if you feel better sooner, to ensure the infection is completely cleared.

Q: What are the common side effects of Cephadroxil?

Like all medications, Cephadroxil can cause side effects, though not everyone experiences them. The most common side effects are often related to the digestive system and include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Stomach upset

Less common side effects may include yeast infections (oral or vaginal) and allergic reactions like rash. If you experience severe or persistent side effects, contact your healthcare provider.

Q: Can I drink alcohol while taking Cephadroxil?

Generally, alcohol does not cause a dangerous interaction with Cephadroxil itself. However, it is usually best to limit or avoid alcohol while you are sick and taking antibiotics. Alcohol consumption may worsen some of the common side effects of the antibiotic, such as nausea or stomach upset, and could potentially interfere with your body's ability to recover from the infection.

Q: What should I do if I miss a dose of Cephadroxil?

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose. If you frequently miss doses, speak with your healthcare provider or pharmacist.

How should Cephadroxil be stored and disposed of?

How to Store and Dispose of Cefadroxil

Official storage conditions differ between the forms of Cefadroxil. Capsules, tablets, and the powder for suspension must be stored at controlled room temperature (20 C to 25 C) away from excess heat, moisture, and light. They must be kept in a tightly closed container.

The reconstituted oral suspension must be refrigerated immediately and must not be frozen.

Product Form Temperature Requirement Stability Limit
Capsules/Tablets/Powder Room Temperature Until Expiration Date
Reconstituted Liquid Refrigerate (2 C to 8 C) Discard after 14 days

All forms must be kept out of the reach of children. Unused or expired medicine should be disposed of via a drug take-back program or by following official household trash instructions; do not keep outdated medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cephadroxil found in:

A-Z Index: